{
    "eid": "2-s2.0-85111105011",
    "title": "Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data",
    "cover-date": "2022-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        }
    ],
    "keywords": [
        "clinical medicine",
        "drug monitoring",
        "education",
        "hospital",
        "microbiology",
        "pharmacy",
        "pharmacy service"
    ],
    "authors": [
        "Nyein Hsu Maung",
        "Janthima Methaneethorn",
        "Thitima Wattanavijitkul",
        "Tatta Sriboonruang"
    ],
    "citedby-count": 1,
    "ref-count": 44,
    "ref-list": [
        "The pharmacokinetic and pharmacodynamic properties of vancomycin",
        "Guidelines for therapeutic drug monitoring of vancomycin: a systematic review",
        "Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists",
        "Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists",
        "Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting",
        "Comparison of the area under the curve for vancomycin estimated using compartmental and non-compartmental methods in adult patients with normal renal function",
        "Are vancomycin trough concentrations adequate for optimal dosing?",
        "Hospitalized patients with and without hemodialysis have markedly different vancomycin pharmacokinetics: a population pharmacokinetic model-based analysis",
        "Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies",
        "Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery",
        "Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation",
        "Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function",
        "Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens",
        "Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations",
        "Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis",
        "Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?",
        "Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections",
        "Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens",
        "Influence of mechanical ventilation on the pharmacokinetics of vancomycin administered by continuous infusion in critically ill patients",
        "Investigation of the age dependency of vancomycin clearance by population pharmacokinetic modeling",
        "Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?",
        "Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers",
        "Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance",
        "Population pharmacokinetics of vancomycin in Japanese adult patients",
        "Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis",
        "Population pharmacokinetic parameters of vancomycin in critically ill patients",
        "Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations",
        "Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type",
        "Vancomycin pharmacokinetics in patients with severe burn injuries",
        "Population pharmacokinetics of vancomycin in adult and geriatric patients: comparison of eleven approaches",
        "Population pharmacokinetics of vancomycin in Thai patients",
        "Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study",
        "Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis",
        "Population pharmacokinetics of vancomycin in postoperative neurosurgical patients",
        "Population pharmacokinetics of vancomycin in postoperative neurosurgical patients and the application in dosing recommendation",
        "Pharmacokinetics of vancomycin and dosing recommendations for trauma patients",
        "A population pharmacokinetic model for vancomycin in adult patients receiving extracorporeal membrane oxygenation therapy",
        "Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration",
        "Population pharmacokinetic model for vancomycin used in open heart surgery: model-based evaluation of standard dosing regimens",
        "Population pharmacokinetics of vancomycin in patients undergoing allogeneic hematopoietic stem-cell transplantation",
        "A new population pharmacokinetic model for vancomycin in patients with variable renal function: therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation",
        "Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: population pharmacokinetic modelling and simulations for improved dosing schemes",
        "Considerations in analyzing single-trough concentrations using mixed-effects modeling",
        "Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University\u2019s"
    ]
}